PI3K Mutations Detected in Liquid Biopsy Are Associated With Reduced Sensitivity to CDK4/6 Inhibitors in Metastatic Breast Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Pharmacological Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
PI3K Mutations Detected in Liquid Biopsy Are Associated to Reduced Sensitivity to CDK4/6 Inhibitors in Metastatic Breast Cancer Patients
Pharmacol Res 2020 Oct 10;[EPub Ahead of Print], M Del Re, S Crucitta, G Lorenzini, C De Angelis, L Diodati, D Cavallero, I Bargagna, P Cinacchi, B Fratini, B Salvadori, M Ghilli, M Roncella, A Fontana, R Danesi, F CucchiaraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.